As filed with the Securities and Exchange Commission on March 31, 2015
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
CELLADON CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
33-0971591 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
|
|
11988 El Camino Real, Suite 650
San Diego, California |
|
92130 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2013 Equity Incentive Plan
2013 Employee Stock Purchase Plan
Inducement Grants
(Full
titles of the plans)
Paul B. Cleveland
President and Chief Financial Officer
Celladon Corporation
11988 El Camino Real, Suite 650
San Diego, California 92130
(858) 366-4288
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
Jason L. Kent, Esq.
Cooley LLP 4401 Eastgate
Mall San Diego, California 92121
(858) 550-6000 |
|
Elizabeth E. Reed, Esq.
Vice President, General Counsel and Secretary
Celladon Corporation
11988 El Camino Real, Suite 650
San Diego, CA 92130 (858)
366-4288 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large Accelerated filer |
|
¨ |
|
Accelerated filer |
|
¨ |
|
|
|
|
Non-accelerated filer |
|
x (Do not check if a smaller reporting company) |
|
Smaller reporting company |
|
¨ |
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of securities
to be registered |
|
Amount
to be registered (1) |
|
Proposed maximum offering price per share (2) |
|
Proposed maximum aggregate
offering price (2) |
|
Amount of
registration fee |
2013 Equity Incentive Plan
Common Stock, $0.001 par value per share |
|
1,174,536 shares (3) |
|
$20.74 |
|
$24,359,877 |
|
$2,831 |
2013 Employee Stock Purchase Plan
Common Stock, $0.001 par value per share |
|
234,907 shares (4) |
|
$20.74 |
|
$4,871,972 |
|
$567 |
Inducement Grants
Common Stock, $0.001 par value per share |
|
53,500 shares (5) |
|
$20.74 |
|
$1,109,590 |
|
$129 |
|
|
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement shall also cover any additional shares of the Registrants Common Stock
(Common Stock) that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
(2) |
This estimate is made pursuant to Rule 457(c) and Rule 457(h)(1) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average
of the high and low prices of the Common Stock on March 26, 2015, as reported by The NASDAQ Global Market. |
(3) |
Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Celladon Corporation 2013 Equity Incentive Plan (the 2013 Plan) on January 1, 2015
pursuant to an evergreen provision contained in the 2013 Plan. Pursuant to such provision, on January 1st of each year commencing in 2015 and ending on (and including)
January 1, 2023, the number of shares authorized for issuance under the 2013 Plan is automatically increased by a number equal to: (a) 5% of the total number of shares of capital stock outstanding on December 31 of the preceding
calendar year; or (b) such lesser number of shares of Common Stock as is determined by the Registrants board of directors (the Board) for the applicable year. |
(4) |
Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Celladon Corporation 2013 Employee Stock Purchase Plan (the 2013 ESPP) on January 1, 2015
pursuant to an evergreen provision contained in the 2013 ESPP. Pursuant to such provision, on January 1st of each year commencing in 2015 and ending on (and including)
January 1, 2023, the number of shares authorized for issuance under the 2013 ESPP is automatically increased by a number equal to the lesser of: (a) 1% of the total number of shares of capital stock outstanding on December 31 of the
preceding calendar year; (b) 384,307 shares; or (c) such number of shares of Common Stock as is determined by the Board that is less than (a) and (b). |
(5) |
Represents shares of Common Stock reserved for issuance upon the exercise of outstanding stock options granted, on terms and conditions consistent with stock option grants under the 2013 Plan, as inducement grants
pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. |
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
ITEM 1. |
PLAN INFORMATION. |
Not required to be filed with this Registration Statement.
ITEM 2. |
REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION. |
Not required to be filed
with this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. |
INCORPORATION OF DOCUMENTS BY REFERENCE. |
The following documents previously filed by
the Registrant with the Securities and Exchange Commission (File No. 001-36183) are incorporated by reference into this Registration Statement:
1. The Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange
Commission on March 31, 2015 (the Form 10-K);
2. The Registrants Current Reports on Form 8-K (excluding any
information and exhibits furnished under either Item 2.02 or Item 7.01 thereof), filed with the Securities and Exchange Commission on March 16, 2015 and March 25, 2015; and
3. The description of the Registrants common stock set forth in the registration statement on Form 8-A, filed with the Securities
and Exchange Commission on November 7, 2013, as updated in the Form 10-K with respect to the par value of the Registrants Common Stock, and including any other amendments or reports filed for the purposes of updating this description.
All documents, reports and definitive proxy or information statements filed pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934, as amended (the Exchange Act), after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or
which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents, reports
and definitive proxy or information statements, or portions thereof, which are furnished and not filed in accordance with the rules of the Securities and Exchange Commission shall not be deemed incorporated by reference into this Registration
Statement. Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any
other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement,
except as so modified or superseded.
ITEM 4. |
DESCRIPTION OF SECURITIES. |
Not applicable.
ITEM 5. |
INTERESTS OF NAMED EXPERTS AND COUNSEL. |
Not applicable.
ITEM 6. |
INDEMNIFICATION OF DIRECTORS AND OFFICERS. |
Section 145 of the Delaware General
Corporation Law (DGCL) generally allows the Registrant to indemnify directors and officers for all expenses, judgments, fines and amounts in settlement actually paid and reasonably incurred in connection with any proceedings so long as
such party acted in good faith and in a manner reasonably believed to be in or not opposed to the Registrants best interests and, with respect to any criminal proceedings, if such party had no reasonable cause to believe his or her conduct to
be unlawful. Indemnification may only be made by the Registrant if the applicable standard of conduct set forth in Section 145 has been met by the indemnified party upon a determination made (i) by the Registrants board of directors
by a majority vote of the directors who are not parties to such proceedings, even though less than a quorum, (ii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (iii) by
the stockholders.
The Registrants amended and restated certificate of incorporation and amended and restated bylaws provide for
indemnification of its directors and officers to the fullest extent permitted by law.
As permitted by the Delaware General Corporation
Law, the Registrant has entered into indemnity agreements with each of its directors and executive officers, that require the Registrant to indemnify such persons against any and all costs and expenses (including attorneys, witness or other
professional fees) actually and reasonably incurred by such person in connection with any action, suit or proceeding (including derivative actions), whether actual or threatened, to which any such person may be made a party by reason of the fact
that such person is or was a director or officer or is or was acting or serving as an officer, director, employee or agent of the Registrant or any of its affiliated enterprises, provided that such person acted in good faith and in a manner such
person reasonably believed to be in or not opposed to the Registrants best interests and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set
forth certain procedures that will apply in the event of a claim for indemnification thereunder.
The Registrant has an insurance policy
in place that covers its officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act or otherwise.
Insofar as indemnification for liabilities under the Securities Act may be permitted to the
Registrants directors, officers or controlling persons pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in such Act and is therefore unenforceable.
ITEM 7. |
EXEMPTION FROM REGISTRATION CLAIMED. |
Not applicable.
|
|
|
Exhibit
Number |
|
Description |
|
|
4.1(1) |
|
Amended and Restated Certificate of Incorporation of the Registrant. |
|
|
4.2(2) |
|
Amended and Restated Bylaws of the Registrant. |
|
|
4.3(3) |
|
Form of Common Stock Certificate of the Registrant. |
|
|
5.1 |
|
Opinion of Cooley LLP. |
|
|
23.1 |
|
Consent of Independent Registered Public Accounting Firm. |
|
|
23.2 |
|
Consent of Cooley LLP. Reference is made to Exhibit 5.1. |
|
|
24.1 |
|
Power of Attorney. Reference is made to the signature page hereto. |
|
|
99.1(4) |
|
Celladon Corporation 2013 Equity Incentive Plan and Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder. |
|
|
99.2(5) |
|
Celladon Corporation 2013 Employee Stock Purchase Plan. |
|
|
99.3 |
|
Form of Inducement Stock Option Grant Notice, Option Agreement and Notice of Exercise. |
(1) |
Previously filed as Exhibit 3.1 to the Registrants Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 10, 2014, and incorporated herein by reference. |
(2) |
Previously filed as Exhibit 3.2 to the Registrants Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 10, 2014, and incorporated herein by reference. |
(3) |
Previously filed as Exhibit 4.1 to the Registrants Registration Statement on Form S-1 (File No. 333-191688), originally filed with the Securities and Exchange Commission on October 11, 2013, as amended,
and incorporated herein by reference. |
(4) |
Previously filed as Exhibit 99.3 to the Registrants Registration Statement on Form S-8 (File No. 333-193662), filed with the Securities and Exchange Commission on January 30, 2014, and incorporated
herein by reference. |
(5) |
Previously filed as Exhibit 10.5 to the Registrants Registration Statement on Form S-1 (File No. 333-191688), originally filed with the Securities and Exchange Commission on October 11, 2013, as amended,
and incorporated herein by reference. |
(a) |
The undersigned Registrant hereby undertakes: |
|
(1) |
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |
|
(i) |
To include any prospectus required by section 10(a)(3) of the Securities Act; |
|
(ii) |
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in
volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the Calculation of Registration Fee table in the effective Registration Statement. |
|
(iii) |
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
|
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the Registration Statement is on Form S-8, and the
information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Registrant pursuant to Section 13 or Section 15(d) of
the Exchange Act that are incorporated by reference in the Registration Statement; and
|
(2) |
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(b) |
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrants annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plans annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(c) |
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on
March 31, 2015.
|
|
|
CELLADON CORPORATION |
|
|
By: |
|
/s/ Paul B. Cleveland |
|
|
Paul B. Cleveland |
|
|
President and Chief Financial Officer |
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Krisztina M. Zsebo and Paul B. Cleveland,
and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this
Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and
each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and
on the dates indicated.
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
/s/ Krisztina M. Zsebo,
Ph.D. Krisztina M. Zsebo, Ph.D. |
|
Chief Executive Officer and Member of the Board of Directors
(Principal Executive Officer) |
|
March 31, 2015 |
|
|
|
/s/ Paul B.
Cleveland Paul B. Cleveland |
|
President and Chief Financial Officer
(Principal Financial Officer) |
|
March 31, 2015 |
|
|
|
/s/ Andrew C.
Jackson Andrew C. Jackson |
|
Corporate Controller
(Principal Accounting Officer) |
|
March 31, 2015 |
|
|
|
/s/ Michael
Narachi Michael Narachi |
|
Chairman of the Board of Directors |
|
March 31, 2015 |
|
|
|
/s/ Gregg Alton
Gregg Alton |
|
Member of the Board of Directors |
|
March 31, 2015 |
|
|
|
/s/ Graham Cooper
Graham Cooper |
|
Member of the Board of Directors |
|
March 31, 2015 |
|
|
|
/s/ Joshua Funder,
Ph.D. Joshua Funder, Ph.D. |
|
Member of the Board of Directors |
|
March 31, 2015 |
|
|
|
/s/ Peter K. Honig, M.D.,
M.P.H. Peter K. Honig, M.D., M.P.H. |
|
Member of the Board of Directors |
|
March 31, 2015 |
|
|
|
/s/ Patrick Y. Yang,
Ph.D. Patrick Y. Yang, Ph.D. |
|
Member of the Board of Directors |
|
March 31, 2015 |
EXHIBIT INDEX
|
|
|
Exhibit
Number |
|
Description |
|
|
4.1(1) |
|
Amended and Restated Certificate of Incorporation of the Registrant. |
|
|
4.2(2) |
|
Amended and Restated Bylaws of the Registrant. |
|
|
4.3(3) |
|
Form of Common Stock Certificate of the Registrant. |
|
|
5.1 |
|
Opinion of Cooley LLP. |
|
|
23.1 |
|
Consent of Independent Registered Public Accounting Firm. |
|
|
23.2 |
|
Consent of Cooley LLP. Reference is made to Exhibit 5.1. |
|
|
24.1 |
|
Power of Attorney. Reference is made to the signature page hereto. |
|
|
99.1(4) |
|
Celladon Corporation 2013 Equity Incentive Plan and Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder. |
|
|
99.2(5) |
|
Celladon Corporation 2013 Employee Stock Purchase Plan. |
|
|
99.3 |
|
Form of Inducement Stock Option Grant Notice, Option Agreement and Notice of Exercise. |
(1) |
Previously filed as Exhibit 3.1 to the Registrants Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 10, 2014, and incorporated herein by reference. |
(2) |
Previously filed as Exhibit 3.2 to the Registrants Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 10, 2014, and incorporated herein by reference. |
(3) |
Previously filed as Exhibit 4.1 to the Registrants Registration Statement on Form S-1 (File No. 333-191688), originally filed with the Securities and Exchange Commission on October 11, 2013, as amended,
and incorporated herein by reference. |
(4) |
Previously filed as Exhibit 99.3 to the Registrants Registration Statement on Form S-8 (File No. 333-193662), originally filed with the Securities and Exchange Commission on January 30, 2014, and
incorporated herein by reference. |
(5) |
Previously filed as Exhibit 10.5 to the Registrants Registration Statement on Form S-1 (File No. 333-191688), originally filed with the Securities and Exchange Commission on October 11, 2013, as amended,
and incorporated herein by reference. |
Exhibit 5.1
|
|
|
Jason L. Kent
T: +1 858 550 6044
jkent@cooley.com |
|
|
March 31, 2015
Celladon Corporation
11988 El Camino Real, Suite 650
San Diego, CA 92130
Ladies and Gentlemen:
We have represented Celladon Corporation, a Delaware corporation (the Company), in connection with the filing by the
Company of a Registration Statement on Form S-8 (the Registration Statement) with the Securities and Exchange Commission, covering the offering of up to an aggregate of 1,462,943
shares of the Companys Common Stock, $0.001 par value (the Shares), including (i) 1,174,536 shares (the 2013 Plan Shares) reserved for issuance
pursuant to the Companys 2013 Equity Incentive Plan (the 2013 Plan), (ii) 234,907 shares (the ESPP Shares) reserved for issuance pursuant to the
Companys 2013 Employee Stock Purchase Plan (the 2013 ESPP) and (iii) 53,500 shares (the Inducement Grant Shares) reserved for issuance pursuant to inducement grants made on terms
and conditions consistent with stock option grants under the 2013 Plan.
In connection with this opinion, we have examined and relied upon
the Registration Statement and the related prospectuses, the 2013 Plan and the 2013 ESPP, the Companys Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws and such other documents, records, certificates, memoranda
and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness and authenticity of all documents submitted to us as originals and the conformity to originals
of all documents submitted to us as copies thereof.
Our opinion is expressed only with respect to the federal laws of the United States of America and
the General Corporation Law of the State of Delaware.
On the basis of the foregoing, and in reliance thereon, we are of the opinion that the 2013 Plan
Shares, when sold and issued in accordance with the 2013 Plan and applicable stock option agreement, the ESPP Shares, when sold and issued in accordance with the 2013 ESPP, and the Inducement Grant Shares, when sold and issued in accordance with the
applicable stock option agreement, and in each case when sold and issued in accordance with the Registration Statement and related prospectuses, will be validly issued, fully paid, and nonassessable (except as to shares issued pursuant to certain
deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).
4401 EASTGATE MALL, SAN
DIEGO, CA 92121 T: (858) 550-6000 F: (858) 550-6420 WWW.COOLEY.COM
|
|
|
Jason L. Kent
T: +1 858 550 6044
jkent@cooley.com |
|
|
We consent to the filing of this opinion as an exhibit to the Registration Statement.
Sincerely,
Cooley LLP
|
|
|
By: |
|
/s/ Jason L. Kent |
|
|
Jason L. Kent |
4401 EASTGATE MALL, SAN
DIEGO, CA 92121 T: (858) 550-6000 F: (858) 550-6420 WWW.COOLEY.COM
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2013 Equity Incentive Plan, the 2013 Employee Stock
Purchase Plan and the Inducement Grants of Celladon Corporation of our report dated March 31, 2015, with respect to the consolidated financial statements of Celladon Corporation included in its Annual Report (Form 10-K) for the year ended December
31, 2014, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Diego, California
March 31, 2015
Exhibit 99.3
CELLADON CORPORATION
STOCK OPTION GRANT NOTICE
(INDUCEMENT GRANT OUTSIDE OF
2013 EQUITY INCENTIVE PLAN)
Celladon Corporation (the Company) hereby grants to Optionholder an option to purchase the number of shares of the Companys
Common Stock set forth below. This option is granted outside of the Companys 2013 Equity Incentive Plan (the Plan), and is subject to all of the terms and conditions as set forth in this notice, the Option Agreement,
the Notice of Exercise and the Plan (as if it had been granted pursuant to the Plan) all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Option
Agreement will have the same definitions as in the Plan or the Option Agreement. If there is any conflict between the terms in this notice and the Plan, the terms of the Plan will control.
|
|
|
Optionholder: |
|
|
Date of Grant: |
|
|
Vesting Commencement Date: |
|
|
Number of Shares Subject to Option: |
|
|
Exercise Price (Per Share): |
|
|
Total Exercise Price: |
|
|
Expiration Date: |
|
|
|
|
|
|
|
Type of Grant: |
|
x Nonstatutory Stock Option |
|
|
|
|
|
Exercise Schedule: |
|
x Same as Vesting Schedule |
|
¨ Early Exercise
Permitted |
|
|
Vesting Schedule: |
|
[1/4th of the shares vest one year after the Vesting Commencement Date; the balance of the shares vest monthly thereafter over the next three years, subject to the
optionholders Continuous Service through each such date.] |
|
|
Payment: |
|
By one or a combination of the following items (described in the Option Agreement): |
|
|
|
|
x By cash, check, bank
draft or money order payable to the Company |
|
|
x Pursuant to a
Regulation T Program if the shares are publicly traded |
|
|
x By delivery of
already-owned shares if the shares are publicly traded |
|
|
x Subject to the
Companys consent at the time of exercise, by a net exercise arrangement |
Additional Terms/Acknowledgements: Optionholder acknowledges receipt of, and understands and agrees to,
this Stock Option Grant Notice, the Option Agreement and the Plan. Optionholder acknowledges and agrees that this Stock Option Grant Notice and the Option Agreement may not be modified, amended or revised except as provided in the Plan. Optionholder
further acknowledges that as of the Date of Grant, this Stock Option Grant Notice, the Option Agreement, and the Plan set forth the entire understanding between Optionholder and the Company regarding this option award and supersede all prior oral
and written agreements, promises and/or representations on that subject with the exception of (i) options previously granted and delivered to Optionholder, (ii) any compensation recovery policy that is adopted by the Company or is
otherwise required by applicable law and (iii) any written employment or severance arrangement that would provide for vesting acceleration of this option upon the terms and conditions set forth therein. By accepting this option, Optionholder
consents to receive such documents by electronic delivery and to participate in the Companys equity incentive programs through an on-line or electronic system established and maintained by the Company or another third party designated by the
Company.
|
|
|
|
|
|
|
CELLADON CORPORATION |
|
OPTIONHOLDER: |
|
|
|
By: |
|
|
|
|
|
|
Signature |
|
|
|
Signature |
|
|
|
|
Title: |
|
|
|
Date: |
|
|
|
|
|
|
Date: |
|
|
|
|
|
|
ATTACHMENTS: Option Agreement, 2013 Equity Incentive Plan and Notice of Exercise
ATTACHMENT I
CELLADON CORPORATION
OPTION AGREEMENT
(NONSTATUTORY STOCK OPTION)
INDUCEMENT GRANT OUTSIDE OF
2013 EQUITY INCENTIVE PLAN)
Pursuant to your Stock Option Grant Notice (Grant Notice) and this Option Agreement, Celladon Corporation (the
Company) has granted you an option to purchase the number of shares of the Companys Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice.
The option is granted to you effective as of the date of grant set forth in the Grant Notice (the Date of Grant).
The option is granted in compliance with NASDAQ Listing Rule 5635(c)(4) as a material inducement to you entering into employment with the Company. This option is a Nonstatutory Stock Option and is granted outside, of, but subject to the terms of the
Companys 2013 Equity Incentive Plan (the Plan) and other relevant Plan provisions as if had been granted as a Nonstatutory Stock Option under Section 5 of such Plan.
If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not
explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
The details of your option, in addition to those set forth in the Grant Notice and the Plan, are as follows:
1. VESTING. Subject to the provisions contained herein and the potential vesting acceleration provisions set forth in
Section 11 herein, your option will vest as provided in your Grant Notice. Vesting will cease upon the termination of your Continuous Service.
2. NUMBER OF SHARES AND EXERCISE PRICE. The
number of shares of Common Stock subject to your option and your exercise price per share in your Grant Notice will be adjusted for Capitalization Adjustments.
3. EXERCISE RESTRICTION FOR NON-EXEMPT
EMPLOYEES. If you are an Employee eligible for overtime compensation under the Fair Labor Standards Act of 1938, as amended (that is, a Non-Exempt Employee), and except as otherwise provided in the Plan,
you may not exercise your option until you have completed at least six (6) months of Continuous Service measured from the Date of Grant, even if you have already been an employee for more than six (6) months. Consistent with the provisions
of the Worker Economic Opportunity Act, you may exercise your option as to any vested portion prior to such six (6) month anniversary in the case of (i) your death or disability, (ii) a Corporate Transaction in which your option is
not
assumed, continued or substituted, (iii) a Change in Control or (iv) your termination of Continuous Service on your retirement (as defined in the Companys benefit
plans).
4. EXERCISE PRIOR TO VESTING (EARLY
EXERCISE). If permitted in your Grant Notice (i.e., the Exercise Schedule indicates Early Exercise Permitted) and subject to the provisions of your option, you may elect at any time that is
both (i) during the period of your Continuous Service and (ii) during the term of your option, to exercise all or part of your option, including the unvested portion of your option; provided, however, that:
(a) a partial exercise of your option will be deemed to cover first vested shares of Common Stock and then the earliest vesting
installment of unvested shares of Common Stock;
(b) any shares of Common Stock so purchased from installments that have not vested
as of the date of exercise will be subject to the purchase option in favor of the Company as described in the Companys form of Early Exercise Stock Purchase Agreement; and
(c) you will enter into the Companys form of Early Exercise Stock Purchase Agreement with a vesting schedule that will result in
the same vesting as if no early exercise had occurred.
5. METHOD OF
PAYMENT. You must pay the full amount of the exercise price for the shares you wish to exercise. You may pay the exercise price in cash or by check, bank draft or money order payable to the Company or in any other
manner permitted by your Grant Notice, which may include one or more of the following:
(a) Provided
that at the time of exercise the Common Stock is publicly traded, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock, results in either the receipt of cash (or
check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds. This manner of payment is also known as a broker-assisted exercise, same day sale,
or sell to cover.
(b) Provided that at the time of exercise the Common Stock is publicly traded, by delivery to the
Company (either by actual delivery or attestation) of already-owned shares of Common Stock that are owned free and clear of any liens, claims, encumbrances or security interests, and that are valued at Fair Market Value on the date of exercise.
Delivery for these purposes, in the sole discretion of the Company at the time you exercise your option, will include delivery to the Company of your attestation of ownership of such shares of Common Stock in a form approved by the
Company. You may not exercise your option by delivery to the Company of Common Stock if doing so would violate the provisions of any law, regulation or agreement restricting the redemption of the Companys stock.
(c) Subject to the consent of the Company at the time of exercise, by a net exercise arrangement pursuant to which the
Company will reduce the number of shares of Common Stock issued upon exercise of your option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price. You must pay any remaining balance of the
aggregate exercise price not satisfied by the net exercise in cash or
other permitted form of payment. Shares of Common Stock will no longer be outstanding under your option and will not be exercisable thereafter if those shares (i) are used to pay the
exercise price pursuant to the net exercise, (ii) are delivered to you as a result of such exercise, and (iii) are withheld to satisfy your tax withholding obligations.
6. WHOLE SHARES. You may exercise your option only for whole shares of Common Stock.
7. SECURITIES LAW COMPLIANCE. In no event may you exercise your option unless the shares
of Common Stock issuable upon exercise are then registered under the Securities Act or, if not registered, the Company has determined that your exercise and the issuance of the shares would be exempt from the registration requirements of the
Securities Act. The exercise of your option also must comply with all other applicable laws and regulations governing your option, and you may not exercise your option if the Company determines that such exercise would not be in material compliance
with such laws and regulations (including any restrictions on exercise required for compliance with Treas. Reg. 1.401(k)-1(d)(3), if applicable).
8. TERM. You may not exercise your option before the Date of Grant or after the expiration of the options term.
The term of your option expires, subject to the provisions of Section 5(h) of the Plan, upon the earliest of the following:
(a)
immediately upon the termination of your Continuous Service for Cause;
(b) three (3) months after the termination of your
Continuous Service for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 8(d) below); provided, however, that if during any part of such three (3) month period your option is not
exercisable solely because of the condition set forth in the section above relating to Securities Law Compliance, your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate
period of three (3) months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the
Companys insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service
during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Companys insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your
Continuous Service terminates within six (6) months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of
(x) the later of (A) the date that is seven (7) months after the Date of Grant, and (B) the date that is three (3) months after the termination of your Continuous Service, and (y) the Expiration Date;
(c) twelve (12) months after the termination of your Continuous Service due to your Disability (except as otherwise provided in
Section 8(d)) below;
(d) eighteen (18) months after your death if you die either during your Continuous
Service or within three (3) months after your Continuous Service terminates for any reason other than Cause;
(e) the
Expiration Date indicated in your Grant Notice; or
(f) the day before the tenth (10th) anniversary of the Date of Grant.
9. EXERCISE.
(a) You may exercise the vested portion of your option (and the unvested portion of your option if your Grant Notice so permits) during
its term by (i) delivering a Notice of Exercise (in a form designated by the Company) or completing such other documents and/or procedures designated by the Company for exercise and (ii) paying the exercise price and any applicable
withholding taxes to the Companys Secretary, stock plan administrator, or such other person as the Company may designate, together with such additional documents as the Company may then require.
(b) By exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into
an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of (i) the exercise of your option, (ii) the lapse of any substantial risk of forfeiture to which the shares
of Common Stock are subject at the time of exercise, or (iii) the disposition of shares of Common Stock acquired upon such exercise.
(c) By accepting your option you agree that you will not sell, dispose of, transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any shares of Common Stock or other securities of the Company held by you, for a period of one hundred eighty (180) days following the
effective date of a registration statement of the Company filed under the Securities Act or such longer period as the underwriters or the Company will request to facilitate compliance with FINRA Rule 2711 or NYSE Member Rule 472 or any successor or
similar rules or regulation (the Lock-Up Period); provided, however, that nothing contained in this section will prevent the exercise of a repurchase option, if any, in favor of the Company during the Lock-Up Period.
You further agree to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriters that are consistent with the foregoing or that are necessary to give further effect thereto. In order to enforce the
foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of Common Stock until the end of such period. You also agree that any transferee of any shares of Common Stock (or other securities) of the Company
held by you will be bound by this Section 9(d). The underwriters of the Companys stock are intended third party beneficiaries of this Section 9(d) and will have the right, power and authority to enforce the provisions hereof as
though they were a party hereto.
10. TRANSFERABILITY. Except as otherwise provided in this Section 10, your
option is not transferable, except by will or by the laws of descent and distribution, and is exercisable during your life only by you.
(a) Certain Trusts. Upon receiving written permission from the Board or its duly
authorized designee, you may transfer your option to a trust if you are considered to be the sole beneficial owner (determined under Section 671 of the Code and applicable state law) while the option is held in the trust. You and the trustee
must enter into transfer and other agreements required by the Company.
(b) Domestic Relations Orders. Upon receiving written
permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your option pursuant to the terms of a domestic
relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulation 1.421-1(b)(2) that contains the information required by the Company to effectuate the transfer. You are encouraged
to discuss the proposed terms of any division of this option with the Company prior to finalizing the domestic relations order or marital settlement agreement to help ensure the required information is contained within the domestic relations order
or marital settlement agreement.
(c) Beneficiary Designation. Upon receiving written permission from the Board or its duly
authorized designee, you may, by delivering written notice to the Company, in a form approved by the Company and any broker designated by the Company to handle option exercises, designate a third party who, on your death, will thereafter be entitled
to exercise this option and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, your executor or administrator of your estate will be entitled to exercise this option and receive, on
behalf of your estate, the Common Stock or other consideration resulting from such exercise.
11. CHANGE
IN CONTROL.
(a) If a Change in Control occurs and within three (3) months prior to or
within twelve (12) months after, the effective time of such Change in Control your Continuous Service terminates due to an involuntary termination (not including death or Disability) without Cause or due to a voluntary termination with Good
Reason, then, as of the date of termination of Continuous Service, the vesting and exercisability of your option will be accelerated in full.
(b) Good Reason means that one or more of the following are undertaken by the Company (or successor to the
Company, if applicable) without your express written consent: (i) a material reduction in your annual base salary, which you agree is a reduction of at least 10% of your base salary (unless pursuant to a salary reduction program applicable
generally to the Companys similarly situated employees); (ii) a material reduction in your authority, duties or responsibilities; (iii) a material reduction in the authority, duties, or responsibilities of the supervisor to whom you
are required to report; (iv) a relocation of your principal place of employment with the Company (or successor to the Company, if applicable) to a place that increases your one-way commute by more than fifty (50) miles as compared to your
then-current principal place of employment immediately prior to such relocation (excluding regular travel in the ordinary course of business); provided that if your principal place of employment is your personal residence, this clause
(iv) shall not apply.
(c) If any payment or benefit you would receive from the Company or otherwise in
connection with a Change in Control or other similar transaction (a 280G Payment) would (i) constitute a parachute payment within the meaning of Section 280G of the Code, and (ii) but for this
sentence, be subject to the excise tax imposed by Section 4999 of the Code (the Excise Tax), then any such 280G Payment (a Payment) shall be equal to the Reduced Amount. The
Reduced Amount shall be either (x) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (y) the largest portion, up to and
including the total, of the Payment, whichever amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all
computed at the highest applicable marginal rate), results in your receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment
is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant to clause (x) of the preceding sentence, the reduction shall occur in the manner (the Reduction Method) that results in the
greatest economic benefit for you. If more than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the Pro Rata Reduction Method).
Notwithstanding the foregoing, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment being
subject to taxes pursuant to Section 409A of the Code that would not otherwise be subject to taxes pursuant to Section 409A of the Code, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified
so as to avoid the imposition of taxes pursuant to Section 409A of the Code as follows: (A) as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic benefit for you as determined on an
after-tax basis; (B) as a second priority, Payments that are contingent on future events (e.g., being terminated without cause), shall be reduced (or eliminated) before Payments that are not contingent on future events; and (C) as a third
priority, Payments that are deferred compensation within the meaning of Section 409A of the Code shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A of the
Code.
Unless you and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general tax
compliance purposes as of the day prior to the effective date of the change of control transaction triggering the Payment shall perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor
for the individual, entity or group effecting the change of control transaction, the Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company shall bear all expenses with respect to the
determinations by such accounting firm required to be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to provide its calculations, together with detailed
supporting documentation, to you and the Company within fifteen (15) calendar days after the date on which your right to a 280G Payment becomes reasonably likely to occur (if requested at that time by you or the Company) or such other time as
requested by you or the Company.
If you receive a Payment for which the Reduced Amount was determined pursuant to clause (x) of the
first paragraph of this Section and the Internal Revenue Service determines
thereafter that some portion of the Payment is subject to the Excise Tax, you shall promptly return to the Company a sufficient amount of the Payment (after reduction pursuant to clause
(x) of the first paragraph of this Section so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) in the first paragraph of this
Section, you shall have no obligation to return any portion of the Payment pursuant to the preceding sentence.
12.
OPTION NOT A SERVICE CONTRACT. Your option is not an employment or service contract, and nothing in your option will be deemed to create in any way whatsoever any
obligation on your part to continue in the employ of the Company or an Affiliate, or of the Company or an Affiliate to continue your employment. In addition, nothing in your option will obligate the Company or an Affiliate, their respective
stockholders, boards of directors, officers or employees to continue any relationship that you might have as a Director or Consultant for the Company or an Affiliate.
13. WITHHOLDING OBLIGATIONS.
(a) At the time you exercise your option, in whole or in part, and at any time thereafter as requested by the Company, you hereby
authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a same day sale pursuant to a program developed under Regulation T as promulgated by the
Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise of your
option.
(b) Upon your request and subject to approval by the Company, and compliance with any applicable legal conditions or
restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date
of exercise, not in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be necessary to avoid classification of your option as a liability for financial accounting purposes). If the date of determination
of any tax withholding obligation is deferred to a date later than the date of exercise of your option, share withholding pursuant to the preceding sentence shall not be permitted unless you make a proper and timely election under Section 83(b)
of the Code, covering the aggregate number of shares of Common Stock acquired upon such exercise with respect to which such determination is otherwise deferred, to accelerate the determination of such tax withholding obligation to the date of
exercise of your option. Notwithstanding the filing of such election, shares of Common Stock shall be withheld solely from fully vested shares of Common Stock determined as of the date of exercise of your option that are otherwise issuable to you
upon such exercise. Any adverse consequences to you arising in connection with such share withholding procedure shall be your sole responsibility.
(c) You may not exercise your option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied.
Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company will have no obligation to issue a certificate for such shares of Common Stock or release such shares of
Common Stock from any escrow provided for herein, if applicable, unless such obligations are satisfied.
14. TAX CONSEQUENCES. You hereby agree that the Company does not have a duty to design or administer the
Plan or its other compensation programs in a manner that minimizes your tax liabilities. You will not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your option
or your other compensation. In particular, you acknowledge that this option is exempt from Section 409A of the Code only if the exercise price per share specified in the Grant Notice is at least equal to the fair market value per
share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated with the option.
15. NOTICES. Any notices provided for in your option or the Plan will be given in writing (including electronically) and
will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the
Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this option by electronic means or to request your consent to participate in the Plan by electronic means. By accepting this
option, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
16. GOVERNING PLAN DOCUMENT. Your option is subject to all the provisions of the Plan, the
provisions of which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan. If there is any conflict
between the provisions of your option and those of the Plan, the provisions of the Plan will control. In addition, your option (and any compensation paid or shares issued under your option) is subject to recoupment in accordance with The
DoddFrank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company and any compensation recovery policy otherwise required by applicable law.
17. OTHER DOCUMENTS. You hereby acknowledge receipt of and the right to receive a document providing the
information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus. In addition, you acknowledge receipt of the Companys policy permitting certain individuals to sell shares only during certain
window periods and the Companys insider trading policy, in effect from time to time.
18. EFFECT
ON OTHER EMPLOYEE BENEFIT PLANS. The value of this option will not be included as compensation, earnings, salaries, or other similar terms used when calculating your
benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Companys or any
Affiliates employee benefit plans.
19. VOTING RIGHTS. You will not have voting or any other
rights as a stockholder of the Company with respect to the shares to be issued pursuant to this option until such shares are
issued to you. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing contained in this option, and no action taken pursuant to its provisions,
will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.
20. SEVERABILITY. If all or any part of this Option Agreement or the Plan is declared by any court or governmental
authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Option Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Option Agreement (or part of such a Section) so
declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.
21. MISCELLANEOUS.
(a) The rights and obligations of the Company under your option will be transferable to any one or more persons or entities, and all
covenants and agreements hereunder will inure to the benefit of, and be enforceable by the Companys successors and assigns.
(b) You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the
Company to carry out the purposes or intent of your option.
(c) You acknowledge and agree that you have reviewed your option in
its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your option, and fully understand all provisions of your option.
(d) This Option Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental
agencies or national securities exchanges as may be required.
(e) All obligations of the Company under the Plan and this Option
Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the
Company.
* * *
This Option Agreement will be deemed to be signed by you upon the signing by you of the Stock Option Grant Notice to which it is attached.
ATTACHMENT II
2013 EQUITY INCENTIVE PLAN
ATTACHMENT III
NOTICE OF EXERCISE
NOTICE OF EXERCISE
|
|
|
Celladon Corporation |
|
|
12760 High Bluff Drive Suite 240 |
|
|
San Diego, CA 92130 |
|
Date of Exercise:
|
This constitutes notice to Celladon Corporation (the Company) under my
stock option that I elect to purchase the below number of shares of Common Stock of the Company (the Shares) for the price set forth below.
|
|
|
Type of option (check one): |
|
Nonstatutory |
|
|
Stock option dated: |
|
|
|
|
Number of Shares as to which option is exercised: |
|
|
|
|
Certificates to be issued in name of: |
|
|
|
|
Total exercise price: |
|
$ |
|
|
Cash payment delivered herewith: |
|
$ |
|
|
Value of Shares delivered herewith1: |
|
$ |
|
|
Value of Shares pursuant to net exercise2: |
|
$ |
1 |
Shares must meet the public trading requirements set forth in the option. Shares must be valued in accordance with the terms of the option being exercised, and must be owned free and clear of any liens, claims,
encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from certificate. |
2 |
Celladon Corporation must have established net exercise procedures at the time of exercise, in order to utilize this payment method. |
|
|
|
|
|
Regulation T Program (cashless exercise3): |
|
$ |
|
$ |
By this exercise, I agree (i) to provide such additional documents as you may require pursuant to the
terms of the Celladon Corporation 2013 Equity Incentive Plan and (ii) to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option.
3 |
Shares must meet the public trading requirements set forth in the option. |
CELLADON CORP (NASDAQ:CLDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
CELLADON CORP (NASDAQ:CLDN)
Historical Stock Chart
From Apr 2023 to Apr 2024